Page 24 - Astrazeneca

Covid-19: Serum Institute to halt trial of Oxford vaccine after DCGI notice

On Tuesday, AstraZeneca had decided to stop trials after a participant fell sick with an unexplained illness.

DCGI issues notice to Serum Institute over Oxford's Covid trial suspension

The DGCI sought an immediate reply saying else "it shall be construed that you have no explanation to offer and action deemed fit will be taken against you"

Fauci says Astrazeneca vaccine pause unfortunate but a safety valve

Anthony Fauci said that AstraZeneca's decision to pause global trials of its coronavirus vaccine was unfortunate but not an uncommon safety precaution in a vaccine development process

AstraZeneca Pharma shares dip over 3% after it halts Covid vaccine trials

Shares of AstraZeneca Pharma, closed over 3 per cent lower on Wednesday after its Covid-19 vaccine study was paused following a participant's unexplained illness

MARKET WRAP: Sensex slips 171 pts amid weak global cues; RIL up over 2.5%

All that happened in the markets today.

Covid: India leads world in daily tally; resumes more metro lines today

According to the health ministry, Maharashtra, Andhra Pradesh, Karnataka, Uttar Pradesh and Tamil Nadu account for 62% of total active coronavirus cases in the country

US, European Covid-19 vaccine developers pledge to uphold testing rigour

The promise to play by established rules underlines a highly politicised debate over what action is needed to rein in Covid-19 quickly and to jumpstart global business and trade

AstraZeneca Pharma tanks 13% as parent firm halts Covid-19 vaccine trials

The company, which is formulating and testing the vaccine in collaboration with Oxford University, is among the front-runners for last-stage trials of potential virus vaccine

AstraZeneca Covid-19 vaccine study paused after one 'unexplained' illness

Late-stage studies of AstraZeneca's Covid-19 vaccine candidate are on temporary hold while the company investigates whether a recipient's "potentially unexplained" illness is a side effect of the shot

New launches in key categories to trigger AstraZeneca Pharma's growth

Higher share of patented products, scope for margin improvement and chronic portfolio are key positives

AstraZeneca Pharma hits fresh record high of Rs 4,489; stock surges 15%

The stock of the company was trading higher for the fifth straight day, surging 26 per cent during the period.

Astrazeneca to begin Phase 1/2 clinical trials of Covid vaccine in Japan

Astrazeneca said on Friday it is beginning Phase 1/2 clinical trials in Japan of its coronavirus vaccine candidate

AstraZeneca Pharma India hits fresh record high, up 15% in 8 trading days

AstraZeneca Plc, the company's parent firm, is expected to release initial data on whether a vaccine can stop people from getting the virus on September 15

AstraZeneca begins coronavirus vaccine phase 3 clinical trials in US

The phase 3 trial is being implemented as part of Operation Warp Speed, a multi-agency collaboration led by the US Health and Human Services

AstraZeneca's Covid-19 vaccine candidate begins late-stage US study

The trial is being conducted under U.S. government's Operation Warp Speed program, which aims to accelerate development, manufacturing and distribution of vaccines and treatments for Covid-19

When will India finally have access to coronavirus vaccine?

India commands 40 per cent of global capacity for vaccines which is estimated at 5.7 billion doses

Covid updates: Job loss in India, Australia's 'vaccine must' policy, & more

Maharashtra has more than 600,000 confirmed coronavirus cases, which is almost equivalent to the case tally of the next two worst-affected states - Tamil Nadu and Andhra Pradesh - put together

Australia to give free Covid vaccine doses to citizens: PM Scott Morrison

Prime Minister Scott Morrison said Australia had reached a deal with Swedish-British pharmaceutical company AstraZeneca to receive the Covid-19 vaccine it is developing with Oxford University

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

Expects to complete trials by year-end

Blow to WHO? EU clinches first Covid-19 vaccine deal with AstraZeneca

The EU move could complicate efforts led by the WHO and GAVI, a global alliance for vaccines, to buy shots on behalf of rich and developing countries with a separate scheme